Literature DB >> 520116

Relationship of glucose tolerance and plasma insulin to the incidence of coronary heart disease: results from two population studies in Finland.

K Pyöräla.   

Abstract

The relationship of glucose tolerance to the incidence of coronary heart disease (CHD) has been investigated in two cohorts of Finnish men: 3267 men ages 40--59 yr from the Social Insurance Institution's (SII) Coronary Heart Disease Study and 1059 men ages 30--59 yr from the Helsinki Policemen Study. The relationship of plasma insulin level to the incidence of CHD was also investigated in the Helsinki Policemen Study. An oral glucose lead of 60, 75, or 90 g according to body surface area was used in both studies. In the SII Study, plasma glucose was determined from venous blood samples taken 1 h after glucose load. In the Helsinki Policemen Study, blood glucose was determined from venous blood samples taken at 0, 1, and 2 h, and at a 5-yr reexamination, plasma insulin was measured during OGTT at 0, 1, 2 h. In the SII Study cohort, the 4-yr mortality from CHD and the 4-yr incidence of nonfatal myocardial infarction (MI) did not show a definite relationship to 1-h postload plasma glucose. In the Helsinki Policemen Study cohort, the 5-yr incidence of "hard criteria" CHD (CHD death and nonfatal MI) was significantly related to high 1-h postload blood glucose level but not to fasting or 2-h postload blood glucose levels. 10-yr mortality from CHD was significantly higher in the top quintile of fasting and 1- and 2-h postload blood glucose levels, as was the incidence of "hard criteria" CHD. However, in multivariate analyses including age, systolic blood pressure, plasma cholesterol, and smoking, the blood glucose variables showed no statistically significant independent contribution in predicted risk of CHD. Univariate analyses by quintiles of plasma insulin levels measured at the 5-yr reexamination showed that the incidence of "hard criteria" CHD during the subsequent 5 yr was significantly higher in the top quintiles of fasting and 1-h and 2-h postload plasma insulin than in the combined lower quintiles. Multivariate analyses showed that the value of high 1-h or 2-h postload plasma insulin level for predicting CHD risk was independent of other risk factors, including blood glucose levels during OGTT.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 520116     DOI: 10.2337/diacare.2.2.131

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  88 in total

1.  Hyperinsulinemia does not change atherosclerosis development in apolipoprotein E null mice.

Authors:  Christian Rask-Madsen; Erica Buonomo; Qian Li; Kyoungmin Park; Allen C Clermont; Oluwatobi Yerokun; Mark Rekhter; George L King
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-03-15       Impact factor: 8.311

2.  Impacts of components of the metabolic syndrome on health status and survival in an aged population.

Authors:  O Lindberg; R S Tilvis; T E Strandberg; J Valvanne; S Sairanen; C Ehnholm; J Tuomilehto
Journal:  Eur J Epidemiol       Date:  1997-06       Impact factor: 8.082

3.  Syndrome X: implications for African Americans.

Authors:  S A Peter
Journal:  J Natl Med Assoc       Date:  1992-03       Impact factor: 1.798

4.  Relationship between plasma insulin levels and high density lipoprotein cholesterol levels in healthy men.

Authors:  M Stalder; D Pometta; A Suenram
Journal:  Diabetologia       Date:  1981-12       Impact factor: 10.122

Review 5.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

Review 6.  The heart in diabetes.

Authors:  D J Kereiakes; J L Naughton; B Brundage; N B Schiller
Journal:  West J Med       Date:  1984-04

7.  Interrelation between plasma testosterone and plasma insulin in healthy adult men: the Telecom Study.

Authors:  D Simon; P Preziosi; E Barrett-Connor; M Roger; M Saint-Paul; K Nahoul; L Papoz
Journal:  Diabetologia       Date:  1992-02       Impact factor: 10.122

8.  Prevalence of coronary heart disease, left ventricular failure and hypertension in middle-aged, newly diagnosed type 2 (non-insulin-dependent) diabetic subjects.

Authors:  M Uusitupa; O Siitonen; A Aro; K Pyörälä
Journal:  Diabetologia       Date:  1985-01       Impact factor: 10.122

9.  Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study.

Authors:  A Fontbonne; E Eschwège; F Cambien; J L Richard; P Ducimetière; N Thibult; J M Warnet; J R Claude; G E Rosselin
Journal:  Diabetologia       Date:  1989-05       Impact factor: 10.122

10.  Plasma insulin and cardiovascular mortality in non-diabetic European men and women: a meta-analysis of data from eleven prospective studies.

Authors: 
Journal:  Diabetologia       Date:  2004-07-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.